Geisa Nascimento Barbalho

Dr. Geisa Nascimento Barbalho

University of Brasília
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
GBGeisa Nascimento Barbalho
Geisa Nascimento Barbalho
BMBreno Matos
Breno Matos
GBGabriel Ferreira da Silva Brito
Gabriel Ferreira da Silva Brito
TMThamires Da Cunha Miranda
Thamires Da Cunha Miranda
TAThuany Alencar-Silva
Thuany Alencar-Silva
TGTaís Gratieri
Taís Gratieri
Scarless skin regeneration is a challenge in regenerative medicine. Herein, we explore the regenerative potential of a Cupuaçu seed extract (Theobroma grandiflorum) to develop an innovative skin regeneration formulation based on chitosan-coated nanocapsules. Cupuaçu seed extract significantly stimulated cell proliferation and migration. A reparative gene expression profile could be verified following extract treatment, which included high levels of MKI67, a cellular proliferation marker, and extracellular matrix genes, such as ELN and HAS2, which code for elastin and hyaluronic acid synthase 2. Formulations with Cupuaçu seed extract successfully entrapped into nanocapsules (EE% > 94%) were developed. Uncoated or coated nanocapsules with low-molecular-weight chitosan presented unimodal size distribution with hydrodynamic diameters of 278.3 ± 5.0 nm (PDI = 0.18 ± 0.02) and 337.2 ± 2.1 nm (PDI = 0.27 ± 0.01), respectively. Both nanosystems were physically stable for at least 120 days and showed to be non-irritating to reconstructed human epidermis. Chitosan coating promoted active penetration into undamaged skin areas, which were still covered by the stratum corneum. In conclusion, the present study demonstrated for the first time the biotechnological potential of the frequently discarded Cupuaçu seed as a valuable pharmaceutical ingredient to be used in regenerative skin products.

15 September 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
GBGeisa Nascimento Barbalho
Geisa Nascimento Barbalho
MFManuel A. Falcão
Manuel A. Falcão
JLJefferson M. S. Lopes
Jefferson M. S. Lopes
JLJúlia M. Lopes
Júlia M. Lopes
JCJonad Logan Adriano Contarato
Jonad Logan Adriano Contarato
TGTaís Gratieri
Taís Gratieri
Animal models are still used in the research and development of ophthalmic drug products, mainly due to the difficulty in simulating natural physiological conditions with in vitro models, as there is a lack of dynamic protection mechanisms. Therefore, developing alternative ophthalmic models that evaluate drug penetration in the cornea while applying dynamic protection barriers is a contemporary challenge. This study aimed to develop a dynamic ex vivo model using porcine eyes with a simulated lacrimal flow to evaluate the performance of pharmaceutical drug products. A glass donor cell to support a simulated tear flow was designed, optimized, and custom-made. The system was challenged with different formulations (with fluconazole) including excipients with different viscosities (poloxamer 407) and mucoadhesive properties (chitosan). The results were compared to those obtained from a conventional excised cornea model mounted in Franz-type diffusion cells. The dynamic model could differentiate formulations, while the static model did not, overestimating ex vivo drug penetrated amounts. Hence, the dynamic model with simulated tear flow showed to be a simple and promising new alternative method for the drug penetration of ophthalmic formulations that ultimately can reduce the number of animals used in research.

27 November 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JAJayanaraian Martins Andrade
Jayanaraian Martins Andrade
BMBreno Matos
Breno Matos
RRRafael Vieira Rocho
Rafael Vieira Rocho
GBGeisa Nascimento Barbalho
Geisa Nascimento Barbalho
MCMarcilio Cunha-Filho
Marcilio Cunha-Filho
TGTaís Gratieri
Taís Gratieri
Background/Objectives: Although androgenic alopecia is the most prevalent among non-cicatricial alopecia, it still lacks an effective and safe treatment. Dutasteride (DUT) shows promising results in hair regrowth; however, oral DUT intake causes serious sexual adverse events. Hence, we produced liposomes with different bilayer structures and evaluated the capability of such systems in increasing DUT accumulation in the hair follicles. Methods: In vitro skin penetration tests were performed with porcine ear skin, and the follicular targeting factor (Tf) was calculated as the ratio between DUT amount in HFs and DUT recovered from the sum of all skin layers. Results: While the stiffer DUT-loaded liposome was not able to target the hair follicles in 12 h (Tf = 0.15), a DUT-loaded liposome with an edge activator in its composition, i.e., transfersomes, promoted better control over DUT release and a higher Tf (0.32) (p < 0.005). Conclusions: Transfersomes present higher affinity with DUT providing a better controlled release; hence, they are a better option for DUT follicle targeting compared to liposomes. Further formulation optimizations are needed aiming to prolong such targeting effect.

1 April 2021 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
GBGeisa Nascimento Barbalho
Geisa Nascimento Barbalho
BMBreno N. Matos
Breno N. Matos
MSMaria Eduarda L. Espirito Santo
Maria Eduarda L. Espirito Santo
VSVinicius R.C. Silva
Vinicius R.C. Silva
BCBraun Chaves
Braun Chaves
TGTaís Gratieri
Taís Gratieri

6 October 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CRChristian Michael Stefan Raab
Christian Michael Stefan Raab
SBStefan Brugger
Stefan Brugger
JLJara-Sophie Lechner
Jara-Sophie Lechner
GBGeisa Nascimento Barbalho
Geisa Nascimento Barbalho
TGTaís Gratieri
Taís Gratieri
CKCornelia Keck
Cornelia Keck
Objective: This study aimed to investigate the feasibility of using the digital image processing technique, developed to semi-quantitatively study dermal penetration, to study corneal penetration in an ex vivo porcine eye model. Here, we investigated various formulation strategies intended to enhance dermal and corneal bioavailability of the model hydrophobic drug, curcumin. Methods: Several formulation principles were explored, including oily solutions, oily suspensions, aqueous nanosuspension, micelles, liposomes and cyclodextrins. The dermal penetration efficacy was tested using an ex vivo porcine ear model previously developed at Philipps-Universität Marburg with subsequent digital image processing. This image analysis method was further applied to study corneal penetration using an ex vivo porcine whole-eye model. Results: For dermal penetration, oily solutions, oily suspensions and nanosuspensions exhibited the least penetration, whereas liposomes and cyclodextrins showed enhanced penetration. Corneal curcumin penetration correlated with dermal penetration, with curcumin loaded into cyclodextrins penetrating the deepest. Conclusions: Overall, our study suggests that the image analysis method previously developed for ex vivo skin penetration can easily be repurposed to study corneal penetration of hydrophobic drugs.

17 June 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JAJayanaraian Martins Andrade
Jayanaraian Martins Andrade
RRRafael Vieira Rocho
Rafael Vieira Rocho
BMBreno Matos
Breno Matos
GBGeisa Nascimento Barbalho
Geisa Nascimento Barbalho
KNKARIANE Mendes NUNES
KARIANE Mendes NUNES
TGTaís Gratieri
Taís Gratieri
Background/Objectives: Treatment options for androgenic alopecia are still very limited and lack long-term efficacy. Dutasteride (DUT) has gained interest as a potent inhibitor of 5α-reductase, allowing for spaced applications, but DUT oral intake can cause serious adverse effects. Herein, we developed, characterized, and assessed the potential of DUT-loaded ethosomes with increasing ethanolic concentrations for hair follicle (HF) targeting to treat androgenic alopecia, hypothesizing that ethanol’s interaction with HFs’ sebum might increase DUT targeting to the HFs. Methods: Ethosomes were obtained using the water-dropping method. After a hydrodynamic size screening, a 30% ethanol concentration was fixed. Ethosomes with 30% ethanol were also prepared and had their ethanolic content removed by rotary evaporation for the evaluation of ethanol in targeting DUT to the HFs. The targeting factor (Tf) was calculated as the ratio between the DUT amount in HFs and the total DUT amount recovered from all skin layers after in vitro porcine skin penetration tests for 12 and 24 h. Results: The ethanolic concentration affected the vesicles’ size and the targeting potential. While the dried ethosomes could not increase DUT accumulation in the HFs at both time points (Tf: 0.27 in 12 h and Tf: 0.28 in 24 h), the presence of 30% ethanol in the vesicles increased the Tf from 0.28 (12 h) to 0.34 (24 h), significantly superior (p < 0.05) than the dried ethosome and control (Tf: 0.24) in 24 h. Conclusion: Ethosomes with a 30% ethanolic concentration were slightly more efficient in targeting HFs for dutasteride delivery.